<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260121068627N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-02-13</date_registration>
      <primary_sponsor>Birjand University of Medical Sciences</primary_sponsor>
      <public_title>The effect of training and virtual reality glasses on patients' anxiety before cardiac angiography</public_title>
      <acronym></acronym>
      <scientific_title>The effect of teach-back and distraction with virtual reality on patients’ anxiety before coronary angiography</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-02-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>112</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/88822</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Factorial, Purpose: Education/Guidance, Other design features: This study is conducted as a randomized clinical trial with a factorial design. Participants are allocated into four groups: virtual reality, feedback-oriented education, combined intervention, and control. Block randomization is used, and both the outcome assessor and data analyst are blinded to group allocation. All interventions are delivered under similar conditions prior to coronary angiography, Randomization description: This study will be designed as a randomized clinical trial with four parallel groups. After identifying eligible patients and obtaining written informed consent, participants will be assigned to one of four study groups.

Randomization Method (Time-Block Randomization)

This study will use a time-block randomization method. In this way, the study period will be divided into predetermined time blocks (for example, weekly or monthly), and in each time block, only one of the four study groups will be considered as the assigned group.
At the end of each time block, the group assignment will change, and this process will continue until the desired sample size is completed in all four groups. The order of group assignment to time blocks will be determined randomly.

This method will be used to facilitate the implementation of the intervention, prevent interference between interventions, and reduce information contamination between groups, and is classified as a quasi-randomized method.

Randomization unit

The randomization unit in this study will be the individual; however, the allocation of individuals will be based on time blocks, meaning that all patients admitted in any given time period will be placed in the same group assigned to that time block.

Randomization strata

In this study, stratified randomization will not be performed, and background variables such as age, gender, or baseline anxiety severity will not be considered in the group allocation process.

Randomization tool

The order of allocation of the four study groups to time blocks will be determined using a random number table or statistical software (such as SPSS). This process will be performed by a researcher independent of the intervention implementation team.

How to construct a random sequence

First, the time blocks of the study will be defined. Then, using random numbers, the sequence of allocation of the four study groups to these time blocks will be randomly generated. Patients will be assigned to the assigned group in the order they enter the study and based on the relevant time block.

Allocation Concealment

Given the nature of time randomization, complete concealment of allocation at the individual level will not be possible; however, the sequence of allocation of groups to time blocks will be prepared in advance and maintained by the researcher responsible for randomization, and the interventionists will not be aware of the group allocation for that interval until the beginning of each time block. This will be done to reduce selection bias, Blinding description: This study will be designed as a single-blind study with blinding of the outcome assessor and data analyst.
Participants (patients):
Participants will be aware of their inclusion in the study and their allocation to one of the four study groups, and written informed consent will be obtained from all of them. The knowledge of participation in the study will not be hidden from the patients, as this is not ethically permissible. Given the nature of the intervention (feedback-based training and/or virtual reality), it will not be possible to blind the patients to the type of intervention they receive. However, patients will not be informed of the research hypotheses, comparisons between groups, and expected outcomes, and they will be asked to refrain from disclosing details of the intervention when completing the research instruments.

Principal Investigator:
The principal investigator will be aware of the group allocation of patients due to his/her direct role in the design, organization, and implementation of the interventions; however, he/she will not participate in the process of collecting outcome data and statistical analysis to avoid bias.

Healthcare personnel:
Therapeutic personnel (physicians and nurses in the angiography department) who will be responsible for routine patient care will not be involved in the randomization process and allocation of patients to the four study groups and will not be aware of the type of educational intervention received by the patients. Routine care will be provided to all patients in all four groups according to the department's standard protocol.

Data collectors and outcome assessors:
Data collection related to study outcomes, including patient anxiety, will be performed by an individual or individuals who will not be aware of the group allocation of participants to the four study groups. Outcome assessment will be performed based on standard instruments and using anonymous codes for the groups to maintain blinding of the assessors.

Data analysts:
Statistical analysis of the data will be performed by a researcher who will not be aware of the type of intervention and allocation of patients to the four study groups and the data will be provided to him/her in coded form.

Data Safety and Monitoring Committee (DSMC):
Due to the non-invasive and low-risk nature of educational and virtual reality interventions, an independent data safety and monitoring committee will not be formed; however, any potential complications will be recorded and monitored continuously during the study.

Drafters of the article:
A draft of the article will be prepared based on the coded data after data collection and statistical analysis are completed to avoid bias in the interpretation of the results.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Patients who are candidates for angiography.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group one: We converted a 20-minute nature film from YouTube into a 3D format that can be played on virtual reality glasses using programming. We submitted the film to the approval of the cardiologist of the hospital under study. For patients who are candidates for angiography, we will show the film with special glasses for one session, 5 minutes before entering the angiography room, with their consent.Training content:video from nature. Intervention 2: Second intervention group: Educational materials including care before, during, and after angiography that are understandable to patients were prepared by the researcher and approved by the professors and cardiologists of the studied hospital. During a 30-45 minute session, 1 hour before entering the angiography room, the researcher will provide training using a feedback-based training method and the patient will be asked questions until he/she answers 80% of the questions correctly. The training will be repeated.Training content:Educating patients who are candidates for coronary angiography• What is cardiac angiography?Angiography is only a diagnostic method, not a treatment, that provides complete information about the patient's cardiac condition and is considered a low-risk method.Angiography is basically the injection of contrast material into the veins and cavities of the heart and simultaneous X-ray imaging to create an image of the same vessel or cavity in the angiography images. In this way, if there is a stenosis or blockage in the path of the vein or cavities of the heart, the contrast material will not reach those areas and therefore an image of these areas will not be created.To perform angiography, one of the available peripheral veins, such as the femoral artery in the groin or the radial artery in the wrist, is used. Through this vein, long, hollow tubes called "catheters" are guided to the heart, and the rest of the angiography work is performed through these catheters.Possible complications include:Damage to blood vessels, including rupture or bleedingInfection or bruising at the catheter siteAllergic reaction to the dye or contrast usedKidney damage from the dye or contrast usedBlood clots that can lead to stroke or heart attack• Reason for angiographyDiagnosis of coronary artery disease (blockage or narrowing of the arteries)Assess the severity and location of the blockage to decide on treatment (medication, stent, bypass surgery)Investigate the cause of chest pain, shortness of breath, or abnormal heart test resultsEvaluate the condition of the arteries in patients with acute coronary syndrome (ACS) or unstable angina• Preparations before angiographyFasting: Avoid eating solid and heavy foods for at least 4 hours before the procedure. Fluids and liquid foods such as soup are not contraindicated.Medications: Tell your doctor a complete list of medications you are taking (dose and name).Anticoagulants (blood thinners): Your doctor will give you specific instructions on how to stop or adjust your medication before surgery. Never stop your medication without consulting your doctor.Your doctor will adjust your dose of warfarin depending on the reason for taking it.Do not take zaleplon the day before surgery or apixaban the day of surgery.Oral anticoagulants such as aspirin and Plavix are not contraindicated.Metformin (for diabetes): Usually must be stopped 24 to 48 hours before surgery as directed by your doctor (due to the risk of kidney failure after injection of the contrast agent).Currently, depending on the type of contrast agent, metformin does not need to be stopped.If you have diabetes and are taking insulin, you may need to adjust your insulin dose on the day of surgery. Your primary care doctor can help you with this adjustment.Blood pressure and thyroid medications: You can usually take them with a small amount of water the morning of surgery, but be sure to check with your doctor.Allergies: Be sure to tell your doctor about any allergies to medications, especially to iodine or contrast media.Tests: CBC, BUN, Cr, coagulation tests (PT, INR, PTT), blood sugar. These tests can help you determine how well your kidneys and liver are working. They can also show how well your blood is clotting.Catheter site preparation: Trim hair from the upper half of both thighs to the navel (do not shave)Be sure to shower on the day of surgery and wash the catheter site with soap and water.Remove any jewelry, glasses, contacts, or hairpins before surgery.• Care and procedure during angiographyLocation: The procedure is performed in the cardiac catheterization room ("cat lab"). The patient lies on a cat lab table. Heart rate, blood pressure, and oxygen are monitored.Awake: You are usually awake during the procedure and may receive a sedative to reduce stress.Catheter insertion: The radial (wrist) or femoral (groin) artery area is numbed and the catheter is inserted through an artery (vein).Common sensations:You may feel some pressure or mild pain where the catheter is inserted.Duration of the procedure: Usually 20–45 minutes.The treatment team constantly monitors the patient's vital signs.During the angiogram, the doctor will ask you to take a deep breath and hold it.During the angiogram, you may feel hot or warm in your body, which is caused by the injection of the contrast material. You may also feel nauseous at times, which is normal for some people, so there is no need to worry.Your doctor may ask you to cough during angiography, which is to increase your heart rate and, as a result, the contrast material will be expelled from your vessels more quickly.• Post-angiography careCatheter insertion site: Keep the catheter insertion area clean and dry.Absolute rest:In the femoral method (leg angiography): After angiography, stay in bed for 8 hours and do not get up. Try to keep your leg straight and motionless. Do not bend the angiographic leg, move slowly to the back with help.Two sandbags are placed, the first bag should be left on the dressing for one hour and the second bag for 4-6 hours.The area is bandaged with pressure.Inform the nurse if the dressing area becomes hot, wet, or painful.Stay in bed for up to 6 hours, and use a bedpan if you need to use the bathroom.For the first 7 days after the operation, do not strain during bowel movements and use the toilet to prevent bleeding from the catheter insertion site.In the radial method (hand angiography): In the angiography room, a special cuff is placed around the patient's arm, and the air inside is reduced every 30 minutes by the nurse. When the air is completely evacuated, the cuff is opened 1 hour later and a dressing is placed, and the dressing is removed after 12 hours.Do not lift heavy weights with the arm that has undergone angiography for up to 1 week.Bath: From the. Intervention 3: Third intervention group: Combination group - will receive both interventions one and two. Intervention 4: Control group: Will receive routine ward care, including training provided by the shift nurse for pre- and post-angiography care.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data is potentially shareable after de-identification

When:
Access period starts 6 months after results are published.

To whom:
The data will only be available to researchers working in academic and scientific institutions.

Conditions:
Providing a valid code of ethics

Where to obtain:
Email address: hosseinpoorsara53@gmail.com

How to obtain:
Send email

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Sara Hosseinpoor</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 78, Nasrin Street, Ghaffari Boulevard, Birjand, Iran</address>
        <city>Birjand</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9717916717</zip>
        <telephone>+98 56 3234 6110</telephone>
        <email>hosseinpoorsara53@gmail.com</email>
        <affiliation>Birjand University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Sara hosseinpoor</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 78, Nasrin Street, Ghaffari Boulevard, Birjand, Iran</address>
        <city>Birjand</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9717916717</zip>
        <telephone>+98 56 3234 6110</telephone>
        <email>hosseinpoorsara53@gmail.com</email>
        <affiliation>Birjand University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Willingness to participate in the study and completing the written informed consent form
Age 25 to 85 years
The patient's angiography is not an emergency
Ability to communicate verbally
Candidate for the angiography procedure for the first time
No vision or hearing problems
No drug addiction
No use of sedatives
No epilepsy or obvious mental illness (based on the patient's self-report)
No anti-anxiety medication before the procedure
The patient is not part of the treatment team</inclusion_criteria>
      <agemin>25 years</agemin>
      <agemax>85 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Death of the patient
Cancellation of the procedure during the intervention
Change of the patient's condition to emergency for any reason (e.g., arrhythmia)
Unwillingness to continue cooperation
Short waiting time (less than 20 minutes).</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>N/A</i_code>
      <i_code>N/A</i_code>
      <i_code>N/A</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group one: We converted a 20-minute nature film from YouTube into a 3D format that can be played on virtual reality glasses using programming. We submitted the film to the approval of the cardiologist of the hospital under study. For patients who are candidates for angiography, we will show the film with special glasses for one session, 5 minutes before entering the angiography room, with their consent.Training content:video from nature</i_keyword>
      <i_keyword>Second intervention group: Educational materials including care before, during, and after angiography that are understandable to patients were prepared by the researcher and approved by the professors and cardiologists of the studied hospital. During a 30-45 minute session, 1 hour before entering the angiography room, the researcher will provide training using a feedback-based training method and the patient will be asked questions until he/she answers 80% of the questions correctly. The training will be repeated.Training content:Educating patients who are candidates for coronary angiography• What is cardiac angiography?Angiography is only a diagnostic method, not a treatment, that provides complete information about the patient's cardiac condition and is considered a low-risk method.Angiography is basically the injection of contrast material into the veins and cavities of the heart and simultaneous X-ray imaging to create an image of the same vessel or cavity in the angiography images. In this way, if there is a stenosis or blockage in the path of the vein or cavities of the heart, the contrast material will not reach those areas and therefore an image of these areas will not be created.To perform angiography, one of the available peripheral veins, such as the femoral artery in the groin or the radial artery in the wrist, is used. Through this vein, long, hollow tubes called "catheters" are guided to the heart, and the rest of the angiography work is performed through these catheters.Possible complications include:Damage to blood vessels, including rupture or bleedingInfection or bruising at the catheter siteAllergic reaction to the dye or contrast usedKidney damage from the dye or contrast usedBlood clots that can lead to stroke or heart attack• Reason for angiographyDiagnosis of coronary artery disease (blockage or narrowing of the arteries)Assess the severity and location of the blockage to decide on treatment (medication, stent, bypass surgery)Investigate the cause of chest pain, shortness of breath, or abnormal heart test resultsEvaluate the condition of the arteries in patients with acute coronary syndrome (ACS) or unstable angina• Preparations before angiographyFasting: Avoid eating solid and heavy foods for at least 4 hours before the procedure. Fluids and liquid foods such as soup are not contraindicated.Medications: Tell your doctor a complete list of medications you are taking (dose and name).Anticoagulants (blood thinners): Your doctor will give you specific instructions on how to stop or adjust your medication before surgery. Never stop your medication without consulting your doctor.Your doctor will adjust your dose of warfarin depending on the reason for taking it.Do not take zaleplon the day before surgery or apixaban the day of surgery.Oral anticoagulants such as aspirin and Plavix are not contraindicated.Metformin (for diabetes): Usually must be stopped 24 to 48 hours before surgery as directed by your doctor (due to the risk of kidney failure after injection of the contrast agent).Currently, depending on the type of contrast agent, metformin does not need to be stopped.If you have diabetes and are taking insulin, you may need to adjust your insulin dose on the day of surgery. Your primary care doctor can help you with this adjustment.Blood pressure and thyroid medications: You can usually take them with a small amount of water the morning of surgery, but be sure to check with your doctor.Allergies: Be sure to tell your doctor about any allergies to medications, especially to iodine or contrast media.Tests: CBC, BUN, Cr, coagulation tests (PT, INR, PTT), blood sugar. These tests can help you determine how well your kidneys and liver are working. They can also show how well your blood is clotting.Catheter site preparation: Trim hair from the upper half of both thighs to the navel (do not shave)Be sure to shower on the day of surgery and wash the catheter site with soap and water.Remove any jewelry, glasses, contacts, or hairpins before surgery.• Care and procedure during angiographyLocation: The procedure is performed in the cardiac catheterization room ("cat lab"). The patient lies on a cat lab table. Heart rate, blood pressure, and oxygen are monitored.Awake: You are usually awake during the procedure and may receive a sedative to reduce stress.Catheter insertion: The radial (wrist) or femoral (groin) artery area is numbed and the catheter is inserted through an artery (vein).Common sensations:You may feel some pressure or mild pain where the catheter is inserted.Duration of the procedure: Usually 20–45 minutes.The treatment team constantly monitors the patient's vital signs.During the angiogram, the doctor will ask you to take a deep breath and hold it.During the angiogram, you may feel hot or warm in your body, which is caused by the injection of the contrast material. You may also feel nauseous at times, which is normal for some people, so there is no need to worry.Your doctor may ask you to cough during angiography, which is to increase your heart rate and, as a result, the contrast material will be expelled from your vessels more quickly.• Post-angiography careCatheter insertion site: Keep the catheter insertion area clean and dry.Absolute rest:In the femoral method (leg angiography): After angiography, stay in bed for 8 hours and do not get up. Try to keep your leg straight and motionless. Do not bend the angiographic leg, move slowly to the back with help.Two sandbags are placed, the first bag should be left on the dressing for one hour and the second bag for 4-6 hours.The area is bandaged with pressure.Inform the nurse if the dressing area becomes hot, wet, or painful.Stay in bed for up to 6 hours, and use a bedpan if you need to use the bathroom.For the first 7 days after the operation, do not strain during bowel movements and use the toilet to prevent bleeding from the catheter insertion site.In the radial method (hand angiography): In the angiography room, a special cuff is placed around the patient's arm, and the air inside is reduced every 30 minutes by the nurse. When the air is completely evacuated, the cuff is opened 1 hour later and a dressing is placed, and the dressing is removed after 12 hours.Do not lift heavy weights with the arm that has undergone angiography for up to 1 week.Bath: From the</i_keyword>
      <i_keyword>Third intervention group: Combination group - will receive both interventions one and two</i_keyword>
      <i_keyword>Control group: Will receive routine ward care, including training provided by the shift nurse for pre- and post-angiography care.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Anxiety score on the Spielberger Situational Anxiety Inventory. Timepoint: Anxiety was measured at the beginning of the study (before the intervention) and 5 minutes before entering the lab coat room, in 4 groups. Method of measurement: Spielberger Situational Anxiety Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Birjand University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-08-26</approval_date>
        <contact_name>Ethics committee of birjand University of Medical Sciences</contact_name>
        <contact_address>No. 78, between Nasrin 5 and 7, Ghafari St. Birjand South Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
